Test developers exploring new COVID-19 assays for research, clinical applications
Skip to main content
MDHC_Logotype_white
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • This Week's News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • People
    • Regional News
    • Digital Edition
    • CMS approves rule forcing insurers to ease prior authorization
      Biden unveils $1.9T plan to stem virus and steady economy
      HHS removes some requirements for opioid treatment prescribing
      Verma: CMS tried to ‘infuse' free-market competition across healthcare during Trump era
    • Biden unveils $1.9T plan to stem virus and steady economy
      Nursing home staff COVID-19 vaccination: A work in progress
      California hospitals prepare ethical protocol to prioritize lifesaving care
      Expanded vaccine rollout in U.S. spawns a new set of problems
    • Trenda Ray
      Q&A: Arkansas nursing leader looking for creative staffing solutions as COVID cases surge
      The Check Up: Trenda Ray
      The Check Up: Trenda Ray of the University of Arkansas for Medical Sciences
      Cook Lydia 4x6_i.jpg
      Northeast Ohio health systems increase community benefit values in 2019
      Vaccine rollout hits snag as health workers balk at shots
    • CMS approves rule forcing insurers to ease prior authorization
      COVID-19 still a big uncertainty for insurers in 2021
      Health insurers' outlook boosted after Dems' Georgia win
      humana_i.jpg
      Humana supports Ohio not-for-profits with $500,000
    • CMS approves rule forcing insurers to ease prior authorization
      Verma: CMS tried to ‘infuse' free-market competition across healthcare during Trump era
      CMS axes MFAR rule for good
    • Operation Warp Speed to bump up McKesson's stock price
      Reporter's notebook: J.P. Morgan's 2021 health conference
      Hospitals, nursing homes get more time to file cost reports
      Hospitals' 2020 fundraising on pace to top 2019
    • 5 things to know about Google's $2.1B Fitbit acquisition
      Providence bets on machine-learning, consolidating data centers
      Mental health treatment was most common telehealth service during COVID
      Broad, Verily take Terra bioinformatics platform to Microsoft Azure cloud
    • Chance of COVID-19 triage care looms over Arizona hospitals
      U.S. ramps up vaccinations to get doses to more Americans
      367146427.jpg
      Should businesses mandate that staff get the COVID vaccine?
      Smartphone
      'No mobile phone' phobia on the rise
    • Tower Health's finance chief resigning after years of steep losses
      AHRQ director Gopal Khanna resigns in response to Capitol riot
      Brigham president stepping down after Moderna controversy
      Meghan Joyce
      Oscar COO Meghan Joyce describes her management approach
    • Midwest
    • Northeast
    • South
    • West
  • Insights
    • ACA 10 Years After
    • Best Practices
    • InDepth Special Reports
    • Innovations
    • The Affordable Care Act after 10 years
    • New care model helps primary-care practices treat obesity
      doctor with patient
      COVID-19 treatment protocol developed in the field helps patients recover
      Rachel Wyatt
      Project to curb pressure injuries in hospitals shows promise
      Yale New Haven's COVID-19 nurse-staffing model has long-term benefits
    • Dr. James Hildreth
      How medical education can help fight racism
      Modern Healthcare InDepth: Breaking the bias that impedes better healthcare
      Videos: Healthcare industry executives describe their encounters with racism
      Michellene Davis
      Healthcare leadership lacks the racial diversity needed to reduce health disparities
      Hospital divided into multiple pieces
      Health systems may be warming to offshoring, a mainstay practice for insurers
    • A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
      self service station
      COVID-19 pushes patient expectations toward self-service
      Targeting high-risk cancer patients with genetics
      A nurse holds up a phone with a message to a family member saying surgery has started.
      Texting, tablets help hospitals keep family updated on patient care
  • Transformation
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Highmark Health inks six-year cloud, tech deal with Google
      Study: 1 in 5 patients report discrimination when getting healthcare
      HHS proposes changing HIPAA privacy rules
      Android health records app launches at 230 health systems
    • California hospitals prepare ethical protocol to prioritize lifesaving care
      Amazon, JPMorgan Chase, Berkshire Hathaway disband Haven
      Digital pathways poised to reshape healthcare continuum in 2021
      Healthcare was the hardest hit by supply shortages across all U.S. industries
    • A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
      New care model helps primary-care practices treat obesity
      How hospitals are building on COVID-19 telehealth momentum
      Researchers: Hospital price variation exacerbates health inequities
    • MedPAC votes to boost hospital payments, freeze or cut other providers
      Most Next Gen ACOs achieved bonuses in 2019
      Congress recalibrates Medicare Physician Fee Schedule after lobbying
      CMS approves rule to encourage value-based drug pricing
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
    • Health Systems Financials
      Executive Compensation
      Physician Compensation
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
    • Wellstar CEO calls adapting for the pandemic her bold move
      Howard P. Kern
      Recognizing the value of telehealth in its infancy
      Dr. Stephen Markovich
      A bold move helped take him from family doctor to OhioHealth CEO
      Dr. Bruce Siegel
      Why taking a hospital not-for-profit was Dr. Bruce Siegel’s boldest move
    • Barry Ostrowsky
      Ending racism is a journey taken together; the starting point must be now
      Laura Lee Hall and Gary Puckrein
      Increased flu vaccination has never been more important for communities of color
      John Daniels Jr.
      Health equity: Making the journey from buzzword to reality
      Mark C. Clement and David Cook
      We all need to 'do something' to fight inequities and get healthcare right, for every patient, every time
    • Healing healthcare: some ideas for triage by the new Congress, administration
      Dr. Sachin H. Jain
      Medicare for All? The better route to universal coverage would be Medicare Advantage for All
      Connectivity: a social determinant of health that can exacerbate all the others
      Taking my shot at building trust
    • Letters: Eliminating bias in healthcare needs to be ‘deliberate and organic’
      Letters: Maybe dropping out of ACOs is a good thing for patients
      Letters: White House and Congress share blame for lack of national COVID strategy
      Letters: VA making strides to improve state veterans home inspections
    • Sponsored Content Provided By Optum
      How blockchain could ease frustration with the payment process
      Sponsored Content Provided By Optum
      Three steps to better data-sharing for payer and provider CIOs
      Sponsored Content Provided By Optum
      Reduce total cost of care: 6 reasons why providers and payers should tackle the challenge together
      Sponsored Content Provided By Optum
      Why CIOs went from back-office operators to mission-critical innovators
  • Awards
    • Award Programs
    • Nominate
    • Previous Award Programs
    • Other Award Programs
    • Best Places to Work in Healthcare Logo for Navigation
      Nominations Open - Best Places to Work in Healthcare
      Nominations Open - Health Care Hall of Fame
      Nominations Open - 50 Most Influential Clinical Executives
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Top 25 Minority Leaders
    • Top 25 Women Leaders
    • Excellence in Nursing Awards
    • Design Awards
    • Top 25 COOs in Healthcare
    • 100 Top Hospitals
    • ACHE Awards
  • Events
    • Conferences
    • Galas
    • Webinars
    • COVID-19 Event Tracker
    • Leadership Symposium
    • Healthcare Transformation Summit
    • Women Leaders in Healthcare Conference
    • Workplace of the Future Conference
    • Strategic Marketing Conference
    • Social Determinants of Health Symposium
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Minority Leaders Gala (2022)
    • Top 25 Women Leaders Gala
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
    • Carter Dredge
      Next Up Podcast: Ready, set, innovate! Innovation and disruption in healthcare
      Next Up Podcast: COVID-19, social determinants highlight health inequities — what next?
      Ceci Connolly
      Next Up Podcast: How to navigate the murky post-election waters
      Next Up Podcast: Saving Rural Health
    • An older man wearing a mask receiving a vaccine.
      Beyond the Byline: Verifying information on the chaotic COVID-19 vaccine rollout
      doctor burnout
      Beyond the Byline: How healthcare supply chain struggles contribute to employee burnout
      Beyond the Byline: Covering race and diversity in the healthcare industry
      Beyond the Byline: How telehealth utilization has impacted investor-owned company earnings
    • Leading intention promote diversity and inclusion
      Introducing Healthcare Insider Podcast
    • The Check Up: Trenda Ray
      The Check Up: Trenda Ray of the University of Arkansas for Medical Sciences
      The Check Up: Dr. Kenneth Davis
      The Check Up: Dr. Kenneth Davis of Mount Sinai Health System
      The Check Up: Dr. Thomas McGinn
      The Check Up: Dr. Thomas McGinn of CommonSpirit Health
      The Check Up: Mark Ganz
      The Check Up: Mark Ganz of Cambia Health Solutions
    • Video: Ivana Naeymi Rad of Intelligent Medical Objects
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Clinical
August 14, 2020 12:46 PM

Test developers exploring new COVID-19 assays for research, clinical applications

Adam Bonislawski, 360Dx
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print

    While much of the discussion around immunity to SARS-CoV-2 has focused on antibodies, a growing body of research indicates other components of the immune system may play a significant role in combating COVID-19.

    Specifically, the T cell-mediated immune response has become an area of interest with a number of groups exploring its role and several parties developing tests to assess T-cell response for research and vaccine development and perhaps ultimately in the clinic.

    Serology tests measuring antibodies produced in response to COVID-19 infection have been widely used since the spring to assess whether people have been exposed to the virus and to determine how widely the virus has spread throughout populations. A number of reports have observed, though, that in many people this antibody response wanes relatively quickly after their recovery, suggesting that serology testing could miss people who were infected but whose anti-SARS-CoV-2 antibodies have since dropped below detectable levels.

    At the same time, the T-cell response to the virus appears to be more enduring, which suggests that assays for measuring that response could detect cases missed by molecular or antibody testing.

    "You missed the window for PCR, and you missed the window for antibodies, but we know that T cells to coronavirus can be detected 18, 20 years after exposure, so it's a kind of permanent footprint of the virus having been there," said Daniel Altmann, professor of immunology at Imperial College London.

    What exactly that means for immunity to the virus is yet to be worked out, Altmann noted. "The jury is still out on that. There's no data yet."

    Antonio Bertoletti, a professor of infectious disease at Duke-NUS Medical School in Singapore, is working with colleagues to develop a test to measure patient T-cell response to SARS-CoV-2 that he said he plans to offer for clinical use.

    In a study published last month in Nature, a team led by Bertoletti looked at SARS-CoV-2-specific T-cell responses to several peptides from the virus in subjects with COVID-19, SARS, and uninfected controls, finding T-cell reactivity both among COVID and SARS patients as well as in some patients who had not been infected or exposed to either virus.

    Bertoletti said that while unexposed subjects do show some T-cell reactivity, he and his colleagues have found that they had T cells against, at most, one or two SARS-CoV-2 proteins. On the other hand, patients who were infected and recovered from the virus have showed reactivity against at least three to four virus proteins, he said.

    Bertoletti said he believed a test assessing the breadth of a person's T-cell response could prove useful for determining their susceptibility to the disease.

    "I'm convinced that to have an idea of whether we can control the [virus] through our immune system, we should test not only antibodies, but interrogate both arms of adaptive immunity," he said. "Only an analysis of the presence of antibodies and T cells in large patient populations can reveal what are the real correlates of protection."

    One challenge, he noted, is determining what SARS-CoV-2 proteins to test against.

    "It might be that T cells specific for different SARS-CoV-2 proteins have similar protective effects," he said. "Or maybe one can be more important than others. We still don't know."

    SARS-CoV-2 has a relatively large proteome, making it impractical to test for reactivity against all the virus' proteins. Bertoletti said he and his colleagues are building an assay that will test three to four structural proteins from the virus that they believe are likely important in generating a T-cell response.

    He said the assay they were working on differed from the traditional Elispot approach used to study T-cell response in that they performed it in whole blood as opposed to isolated peripheral blood mononuclear cells. This, he noted, allows them to skip the PBMC isolation step, making for a higher-throughput assay.

    "Our idea is to make a test that is quick, that can be run in eight to 12 hours," he said. "A single operator should be able to run around 100 samples a day. It won't be as easy as classic serological tests for antibody detection, but it will be less complicated than the [T-cell] assays that are used at the moment in research labs."

    Bertoletti added that he and his colleagues are forming a company to commercialize the test and are exploring possible collaborations with diagnostic firms but did not provide further details.

    Other parties are also working to bring T cell tests to market. During PerkinElmer's Q2 earnings call last month, President and CEO Prahlad Singh said that the company has "several assays in development" that "will aid researchers and clinicians in understanding how the broader immune system may help for protection, including a patient's T cell response, cytokine levels, or cellular damage."

    He added that while it was not yet clear what role assays for T cell response might play in the clinic or clinical research, "immune insights are going to be important, and that's where sort of we are trying to focus on as to what aspects and what avenues do we need to look at.

    The company declined to provide further information about its work in this area.

    Deepak Nath, president of laboratory diagnostics at Siemens Healthineers, said that his company is also exploring testing for T cell response to SARS-CoV-2, though he noted that the firm "was not in a position to say that we have a path forward or anything like that at this point."

    In July, Cardiff, Wales-based immunodiagnostics firm Indoor Biotechnologies said it had received £50,000 ($65,000) in funding from Innovate UK to support develop a T-cell response test in collaboration with researchers at the School of Medicine, Cardiff University.

    Also in the UK, diagnostics firm Oxford Immunotec launched in May a T-cell response test based on its T-Spot platform. Called the T-Spot Discovery SARS-CoV-2 test kit, the assay is intended for research use but could ultimately find a place in the clinic said CEO Peter Wrighton-Smith. The company currently offers clinical T-cell immunity tests for identifying tuberculosis and cytomegalovirus based on the T-Spot platform.

    "I think we can hypothesize a few potential [clinical] use cases that might emerge," he said. "The first is, if we really want to be sure about diagnosing someone, recognizing that both PCR and antibodies can be negative, we might want to throw T cells into the mix in certain situations."

    He added that such a test could prove useful for assessing the true extent of exposure in populations, particularly given observations that antibody levels can wane several months after infection.

    Measuring exposure could also be important for vaccine development and clinical trials, Wrighton-Smith noted. "Vaccine companies are going to need to know if the people they enroll into their [clinical trial] cohorts, have they had it or not. Because if they have had it, they might have some preexisting immunity … and if companies are only using antibody testing, they are going to miss some people."

    For now, Wrighton-Smith said, the research-use version of the test is drawing customers from three main areas — academic groups doing basic research into immunity and COVID-19; government programs exploring T-cell testing as a possible addition to serology for understanding disease spread; and vaccine development.

    "We've seen a significant increase in interest for our test on the back of the scientific and general community starting to realize the importance of T cells," he said.

    This story first appeared in our sister publication 360Dx, which provides in-depth coverage of in vitro diagnostics and the clinical lab market.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    J&J in 'final stages' of analyzing trial results for its one-dose COVID vaccine
    J&J in 'final stages' of analyzing trial results for its one-dose COVID vaccine
    Should vaccine volunteers now get the real thing?
    Should vaccine volunteers now get the real thing?
    Sponsored Content
    Get Free Newsletters

    Sign up for free enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today

    The weekly magazine, websites, research and databases provide a powerful and all-encompassing industry presence. We help you make informed business decisions and lead your organizations to success.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS
    • Instagram

    Stay Connected

    Join the conversation with Modern Healthcare through our social media pages

    MDHC_Logotype_white
    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2021. Crain Communications, Inc. All Rights Reserved.
    • News
      • This Week's News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition
    • Insights
      • ACA 10 Years After
      • Best Practices
      • InDepth Special Reports
      • Innovations
    • Transformation
      • Patients
      • Operations
      • Care Delivery
      • Payment
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Award Programs
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Top 25 Minority Leaders
        • Top 25 Women Leaders
      • Nominate
      • Previous Award Programs
        • Excellence in Nursing Awards
        • Design Awards
        • Top 25 COOs in Healthcare
      • Other Award Programs
        • 100 Top Hospitals
        • ACHE Awards
    • Events
      • Conferences
        • Leadership Symposium
        • Healthcare Transformation Summit
        • Women Leaders in Healthcare Conference
        • Workplace of the Future Conference
        • Strategic Marketing Conference
        • Social Determinants of Health Symposium
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Minority Leaders Gala (2022)
        • Top 25 Women Leaders Gala
      • Webinars
      • COVID-19 Event Tracker
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing